Evaluation of the Effects of Laughter Yoga
Evaluation of the Effects of Laughter Yoga on Pain Intensity, Stress, and Beta-endorphin Levels in Patients With Multiple Sclerosis
What it found
No result yet.
What was tested
Treatment tested
- Laughter Yoga
What it measured
Main measures
Change in pain intensity measured by Visual Analog Scale (VAS) at [time point]
Baseline and week 4
Pain
Other measures (2)
Fatigue Level
1 month
FatigueChange in plasma beta-endorphin levels measured by ELISA at baseline and week 4
Baseline and week 4
Who could take part
MS (type not specified) · 18 and over
Show the full criteria
Inclusion criteria
* • Being over 18 years old * Being able to communicate adequately * Volunteering to participate in the research
Exclusion criteria
* Unwillingness to participate in the study Having severe cognitive impairment that prevents understanding or participation in the intervention Having a psychiatric disorder that may affect participation in the study Experiencing an acute MS relapse during the study period Having another serious neurological or chronic disease that may affect the study outcomes Regular participation in another complementary therapy program similar to laughter yoga Communication problems that prevent participation in the intervention sessions
As registered. Criteria can change, so ask the trial team or your neurologist.
Contact details on the registryAbout this trial
In the sponsor's words
This randomized controlled study aims to evaluate the effects of laughter yoga on pain intensity, fatigue, and beta-endorphin levels in patients with Multiple Sclerosis. Laughter yoga, a complementary therapy combining breathing exercises and laughter techniques, may help improve symptom management and psychological well-being in individuals with MS.
Loading reviews and guidelines…
History
Started
Mar 2026
Main results due
Jul 2026
Finished
Aug 2026